These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 9702850)
21. The JAK1 Inhibitor Upadacitinib Has No Effect on the Pharmacokinetics of Levonorgestrel and Ethinylestradiol: A Study in Healthy Female Subjects. Mohamed MF; Trueman S; Feng T; Friedman A; Othman AA J Clin Pharmacol; 2019 Apr; 59(4):510-516. PubMed ID: 30500075 [TBL] [Abstract][Full Text] [Related]
22. Effects of the selective AMPA modulator NBI-1065845 on the pharmacokinetics of midazolam or ethinyl estradiol-levonorgestrel in healthy adults. Lin S; Ionescu A; Maynard-Scott J; Kennedy M; Walling DP; Furey M; Singh JB Clin Transl Sci; 2024 May; 17(5):e13791. PubMed ID: 38700236 [TBL] [Abstract][Full Text] [Related]
23. Single- and multiple-dose pharmacokinetics of a low-dose oral contraceptive in women with chronic renal failure undergoing peritoneal dialysis. Price TM; Dupuis RE; Carr BR; Stanczyk FZ; Lobo RA; Droegemueller W Am J Obstet Gynecol; 1993 May; 168(5):1400-6. PubMed ID: 8498419 [TBL] [Abstract][Full Text] [Related]
24. Comparison of contraceptive acceptability of levonorgestrel and ethinyl oestradiol administered in one three-phasic (Trionetta) and one monophasic (Neovletta) version. Carlborg L Contraception; 1983 May; 27(5):439-52. PubMed ID: 6349925 [TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of a triphasic oral contraceptive containing desogestrel and ethinyl estradiol. Archer DF; Timmer CJ; Lammers P Fertil Steril; 1994 Apr; 61(4):645-51. PubMed ID: 8150105 [TBL] [Abstract][Full Text] [Related]
26. Estimating systemic exposure to ethinyl estradiol from an oral contraceptive. Westhoff CL; Pike MC; Tang R; DiNapoli MN; Sull M; Cremers S Am J Obstet Gynecol; 2015 May; 212(5):614.e1-7. PubMed ID: 25511238 [TBL] [Abstract][Full Text] [Related]
27. Pharmacodynamic effects of ethinyl estradiol in women using vaginal devices releasing small doses of levonorgestrel at a constant rate. Toddyvalla V; Johannisson E; Landgren BM; Cekan SZ; Diczfalusy E Contraception; 1983 Jul; 28(1):21-39. PubMed ID: 6414759 [TBL] [Abstract][Full Text] [Related]
28. Effects of Flibanserin on the Pharmacokinetics of a Combined Ethinylestradiol/Levonorgestrel Oral Contraceptive in Healthy Premenopausal Women: A Randomized Crossover Study. Johnson-Agbakwu C; Brown L; Yuan J; Kissling R; Greenblatt DJ Clin Ther; 2018 Jan; 40(1):64-73. PubMed ID: 29198449 [TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of contraceptive steroids in patients with cystic fibrosis. Stead RJ; Grimmer SF; Rogers SM; Back DJ; Orme ML; Hodson ME; Batten JC Thorax; 1987 Jan; 42(1):59-64. PubMed ID: 3112991 [TBL] [Abstract][Full Text] [Related]
30. The effect of deliberate omission of Trinordiol or Microgynon on the hypothalamo-pituitary-ovarian axis. Smith SK; Kirkman RJ; Arce BB; McNeilly AS; Loudon NB; Baird DT Contraception; 1986 Nov; 34(5):513-22. PubMed ID: 3102162 [TBL] [Abstract][Full Text] [Related]
31. Lack of cytochrome P450 1A2 interaction effect of ABT-761 on the pharmacokinetics of theophylline. Wong SL; Cavanaugh JH; Qian J; Hansen R; Awni WM Am J Ther; 1998 Sep; 5(5):303-6. PubMed ID: 10099073 [TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of ethinylestradiol and levonorgestrel after administration of two oral contraceptive preparations. Carol W; Klinger G; Jäger R; Kasch R; Brandstädt A Exp Clin Endocrinol; 1992; 99(1):12-7. PubMed ID: 1628691 [TBL] [Abstract][Full Text] [Related]
33. Zibotentan Can Be Co-administered with Contraceptives Containing Ethinyl Estradiol and Levonorgestrel: A Pharmacokinetic Drug-Drug Interaction Study. Mercier AK; Kois AK; Karsanji D; Baldry R; Birve F; Hedwall M; Molodetskyi O; Gillen M Clin Pharmacol Ther; 2024 Aug; 116(2):372-379. PubMed ID: 38686600 [TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of cyproterone acetate and ethinylestradiol in 15 women who received a combination oral contraceptive during three treatment cycles. Kuhnz W; Staks T; Jütting G Contraception; 1993 Dec; 48(6):557-75. PubMed ID: 8131397 [TBL] [Abstract][Full Text] [Related]
35. Dose-proportional pharmacokinetics of a new 5-lipoxygenase inhibitor, ABT-761, in healthy volunteers. Wong SL; Drajesk J; Chang MS; Witt G; Awni WM Biopharm Drug Dispos; 1998 Apr; 19(3):159-62. PubMed ID: 9569998 [TBL] [Abstract][Full Text] [Related]
36. Estimating systemic exposure to levonorgestrel from an oral contraceptive. Basaraba CN; Westhoff CL; Pike MC; Nandakumar R; Cremers S Contraception; 2017 Apr; 95(4):398-404. PubMed ID: 28041990 [TBL] [Abstract][Full Text] [Related]
37. Gabapentin does not interact with a contraceptive regimen of norethindrone acetate and ethinyl estradiol. Eldon MA; Underwood BA; Randinitis EJ; Sedman AJ Neurology; 1998 Apr; 50(4):1146-8. PubMed ID: 9566412 [TBL] [Abstract][Full Text] [Related]
38. Atogepant Has No Clinically Relevant Effects on the Pharmacokinetics of an Ethinyl Estradiol/Levonorgestrel Oral Contraceptive in Healthy Female Participants. Ankrom W; Xu J; Vallee MH; Dockendorf MF; Armas D; Boinpally R; Min KC J Clin Pharmacol; 2020 Sep; 60(9):1157-1165. PubMed ID: 32297990 [TBL] [Abstract][Full Text] [Related]
39. Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin. Bergink W; Assendorp R; Kloosterboer L; van Lier W; Voortman G; Qvist I Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 2):2132-7. PubMed ID: 2147817 [TBL] [Abstract][Full Text] [Related]
40. Effect of ticagrelor on the pharmacokinetics of ethinyl oestradiol and levonorgestrel in healthy volunteers. Butler K; Teng R Curr Med Res Opin; 2011 Aug; 27(8):1585-93. PubMed ID: 21692601 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]